期刊文献+

“抑肝纤”对大鼠实验免疫损伤性肝纤维化阻断作用的研究 被引量:3

Preventing Hepatic Fibrosis From Experimental Rates Immuno--damaged
暂未订购
导出
摘要 目的本研究利用人血白蛋白免疫损伤Wister大鼠造成肝纤维化模型,以观察“抑肝纤”对大鼠肝纤维化的阻断作用。方法将不同浓度中药“抑肝纤”用于治疗组并与模型组和对照组进行对比,综合分析血清肝纤维化指标、肝组织病理改变、肝组织胶原纤维和网状纤维病理图像定量分析等结果。结果治疗组血清肝纤维化指标(PCⅢ、HA、LN)均低于模型组,接近正常组,差异有显著性(P<0.001或P<0.05)。光镜下肝组织病理变化,肝组织中胶原纤维和网状纤维病理图像定量分析结果治疗组优与模型组,尤以低浓度组更为明显(P<0.005或P<0.05)。结论研究结果表明,中药“抑肝纤”如能早期应用。 Aims:In order to observe the effects of troditional herbs Yi gan xian preventing hepatic fibrosis from experimental rats immuno damaged.Metheds:Treatment groups with various doses troditional herbs yi gan xian were compared with model group which were immuno damaged by human serum albumin and control group.Level of serum PCⅢ HA LN,change of hepatic tissue pathology and analysis of collagenous fibers and reticular fibers pathology picture in the liver were synthesized.Results:serum PCⅢ HA LN in the treatment group were lower than model group (P<0.001或P<0.05).Pathology change under microscope and results of analysing collagenous fibers and reticular fibers pathology picture in the liver were obviously better than model group especially in the lower dose group (P<0.005 or P<0.05).Conclussion:If troditional herbs Yi gan xian were early used,it can effectively prevents hepatic fibrosis from experimental rats.
出处 《中国中医基础医学杂志》 CAS CSCD 1998年第9期19-22,共4页 JOURNAL OF BASIC CHINESE MEDICINE
关键词 免疫性肝损伤 肝纤维化 中医药疗法 Liver immuno damaged hepatic fibrosis analysis of hepatic pathology picture troditional herbs Treatment
  • 相关文献

参考文献6

二级参考文献15

共引文献281

同被引文献14

  • 1余姣,徐可树.TGF-β家族在肝纤维化中的不同作用及对策[J].世界华人消化杂志,2006,14(28):2789-2792. 被引量:2
  • 2Wang Y Q,Ikeda K,Ikebe T,et al.Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats[J].Hepatology,2000,32(5):980-989.
  • 3Hepatic Fibrosis Study Group of Chinese Liver Diseases Association.Consensus on evaluation of the diagnosis and efficacy of hepatic fibrosis[J].Chin J Hepatology,2002,10(5):327-328.
  • 4Nieto N,Friedman S L,Cederbaum A I.Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2El-derived reactive oxygen species[J].Hepatology,2002,35 (1):62-73.
  • 5Bissel DM,Roulot D,George J.Transforming growth factor β and the liver.Hepatol,2001,34:859-867.
  • 6Stoop AA,Lupu F,Pannekoek H.Colocalization of thrombin,PAI-1,and vitronectin in the atherosclerotic vessel wall:A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes.Arterioscler Thrombin Vase Biol,2000,20:1143-1149.
  • 7Palmer EM,Beilfuss BA,Nagai T,et al.Tissue Eng,2002,8 (5):893-900.
  • 8Pressor CC, Yen RD, Wu J, Molecular therapy for hepatic injury and fibrosis: where are we[J]. World J Gastroenterel 2006,12:509.
  • 9Wang Y Q, Ikeda K, lkebe T, et al. Inhibition of hepalic slellale cell proliferation and activation by lhe semisynthetie ;malogue of fumagillin TNP-470 in rats[J]. Hepatology., 2000, 32(5):980.
  • 10Shek FW, Benyon RC. Flow can transforming groth factor beta be targeted usefully to combat liver fibrosis [ J ]. Eur J Gastroenterol Fiepato, 2004,16(2) :123.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部